Overview
Determine the effects of the Computerized Symptom Assessment Tool (C-SCAT) versus usual care on the primary outcomes of self-efficacy for symptom management and symptom self-management behaviors
Description
This is a multi-site two-group randomized control trial (RCT) design to evaluate the effects of the Computerized Symptom Assessment Tool (C-SCAT) for improving symptom self-management versus usual care in 126 adolescents and young adults (AYAs) who are within the first three months of a diagnosis of cancer and who are receiving cancer treatment. For this study, cancer treatment will be defined as a prescribed infusion ( e.g., chemotherapy, immunotherapy).
Eligibility
Inclusion Criteria:
- Has received at least 1 cycle of cancer treatment and is within 3 months of initial cancer diagnosis
- Receiving regularly scheduled cancer treatment and will be receiving at least three more cycles
- Reports at least 1 symptom related to cancer and/or its treatment
- Able to speak, read, and write English as required for completion of the C-SCAT and study measures
Exclusion Criteria:
- Cognitive and/or physical inability to complete study measures.